Hopkins, Ashley M. http://orcid.org/0000-0001-7652-4378
Kichenadasse, Ganessan http://orcid.org/0000-0001-9923-5149
McKinnon, Ross A.
Abuhelwa, Ahmad Y.
Logan, Jessica M.
Badaoui, Sarah
Karapetis, Christos S. http://orcid.org/0000-0003-1741-996X
Rowland, Andrew
Sorich, Michael J. http://orcid.org/0000-0003-1999-866X
Funding for this research was provided by:
Cancer Council South Australia
Article History
Received: 5 May 2021
Revised: 7 October 2021
Accepted: 19 October 2021
First Online: 28 October 2021
Competing interests
: RAM, AR and MJS report investigator-initiated project grants from Pfizer, outside the submitted work. CSK reports advisory board roles with AstraZeneca, Merck Sharp & Dohme, Bristol-Myers Squibb and Roche, outside the submitted work. GK, AYA, AMH, SB and JML declare no competing interests.
: Secondary analysis of anonymized clinical trial data was confirmed negligible risk research by the Southern Adelaide Local Health Network, Office for Research and Ethics and was exempt from review.